Mylan Infringed Forest's Savella Drug Patents, Judge Rules
A Delaware federal judge ruled Monday that Mylan Inc.'s attempt to make a generic version of fibromyalgia treatment Savella infringed three patents held by Forest Laboratories Holdings Ltd. and that the...To view the full article, register now.
Already a subscriber? Click here to view full article